Cart
sales@molnova.com
MMP-7-IN-2
CAS No. 2848717-49-5
MMP-7-IN-2( —— )
Catalog No. M37148 CAS No. 2848717-49-5
MMP-7-IN-2 acts as a selective and potent MMP7 inhibitor and can be used to study inflammatory responses and vascular-related diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 591 | In Stock |
|
| 10MG | 1064 | In Stock |
|
| 25MG | 1577 | In Stock |
|
| 50MG | 2074 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMMP-7-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionMMP-7-IN-2 acts as a selective and potent MMP7 inhibitor and can be used to study inflammatory responses and vascular-related diseases.
-
DescriptionMMP-7-IN-2 (comp 16) is a selective MMP7 inhibitor, with an IC50 of 16 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetMMP
-
RecptorMMP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2848717-49-5
-
Formula Weight729.17
-
Molecular FormulaC28H40ClF3N6O9S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (137.14 mM; Ultrasonic )
-
SMILESS(N[C@@H](CCC(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)C)=O)C(C)C)=O)CC(C)C)=O)=O)C(O)=O)(=O)(=O)C1=CC(C(F)(F)F)=C(Cl)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hideaki Tabuse, et al. Discovery of Highly Potent and Selective Matrix Metalloproteinase-7 Inhibitors by Hybridizing the S1' Subsite Binder with Short Peptides. J Med Chem. 2022 Oct 13;65(19):13253-13263.?
molnova catalog
related products
-
TAPI1
TAPI-1, an ADAM17/TACE inhibitor, inhibits shedding of cytokine receptors.
-
Calycosin-7-O-beta-D...
Calycosin 7-O-β-D-glucoside has antimicrobial activity. Calycosin 7-O-β-D-glucoside is anticipated to be a promising anti-HIV agent.
-
Dehydroeffusol
Dehydroeffusol possesses anti-cancer, anxiolytic and sedative properties. Dehydroeffusol inhibits gastric cancer cell growth and tumorigenicity by selectively inducing tumor-suppressive endoplasmic reticulum stress and a moderate apoptosis.
